Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo 6-Month DB	0	46
Total, all-cause mortality	Givosiran 2.5 mg/kg 6-Month DB	0	48
Total, all-cause mortality	Placebo/Givosiran	0	46
Total, all-cause mortality	Givosiran/Givosiran	1	48
Total, all-cause mortality	All Givosiran	1	94
Total, other adverse events	Placebo 6-Month DB	37	46
Total, other adverse events	Givosiran 2.5 mg/kg 6-Month DB	43	48
Total, other adverse events	Placebo/Givosiran	44	46
Total, other adverse events	Givosiran/Givosiran	47	48
Total, other adverse events	All Givosiran	91	94
Total, serious adverse events	Placebo 6-Month DB	4	46
Total, serious adverse events	Givosiran 2.5 mg/kg 6-Month DB	10	48
Total, serious adverse events	Placebo/Givosiran	17	46
Total, serious adverse events	Givosiran/Givosiran	20	48
Total, serious adverse events	All Givosiran	37	94

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03338816/event-totals